Delphine Raucher-Chéné, MD, PhD

headshot-Delphine Raucher-Chené



6875 Boulevard LaSalle
Montréal, QC
H4H 1R3

Researcher, Douglas Research Centre
Psychiatrist, Douglas Mental Health University Institute
Assistant Professor, Department of Psychiatry, McGill University

Theme-Based Group: Youth Mental Health and Early Intervention
Division: Clinical Research


Dr. Raucher-Chéné’s research program focuses on the development of a comprehensive understanding of the cognitive psychopathology of severe mental illness (i.e., bipolar disorder and schizophrenia-spectrum disorder), across stages, from neuroimaging to remediation. The main objectives of this group are:

  1. To develop a cognitive neuroscience program to expand our current knowledge on cognitive impairments in bipolar disorder (BD) and their neuronal substrates using state-of-the-art imaging protocols;
  2. To develop a measurement-based care approach across the different stages of BD disorder, using digital technology;
  3. To implement innovative and effective psychosocial interventions for persons living with BD.

Dr. Raucher-Chéné completed her French MD degree in psychiatry in 2010 and has worked for ten years as a full-time clinician in an academic psychiatric department in France. She furthered her research training by undertaking an M.Sc. in neuropsychology (2012), a Ph.D. in psychology (2018), and a postdoctoral fellowship (2019-2021) at McGill/Douglas under the supervision of Dr. Martin Lepage before joining McGill University as an Assistant Professor in 2023.

  • ISBD Best Poster Awardee (2020) – International Society for Bipolar Disorders Conference
  • Postdoctoral scholarship (2019) Quebec Bio-Imaging Network
  • Short PhD mobility fellowship program (2016) – Reims Champagne-Ardenne University (France) Aston Brain Centre, Aston University, Birmingham, UK
  • Student mobility fellowship program (2002) – Conseil Général du Maine-et-Loire (France)
  • Liverpool School of Medicine, Liverpool, UK

OSF Account

  1. Percie du Sert, O., Unrau, J.*, Gauthier, C. J., Chakravarty, M., Malla, A., Lepage, M., & Raucher-Chéné, D. (2023). Cerebralblood flow in schizophrenia: A systematicreview and meta-analysis of MRI-basedstudies. Progress in Neuro-Psychopharmacology and BiologicalPsychiatry, 121, 110669.
  2. Lavigne, K. M., Sauvé, G., Raucher-Chéné, D., Guimond, S., Lecomte, T., Bowie, C. R., Menon, M., Lal, S., Woodward, T. S., Bodnar, M. D., & Lepage, M. (2022). Remote cognitive assessment in severe mental illness: a scoping review. Schizophrenia, 8(1), 14.
  3. Mendelson, D.*, Thibaudeau, É., Sauvé, G., Lavigne, K. M., Bowie, C. R., Menon, M., Woodward, T. S., Lepage, M., & Raucher-Chéné, D. (2021). Remote group therapies for cognitive health in schizophrenia-spectrum disorders: Feasible, acceptable, engaging. SchizophrResCogn, 100230.
  4. Raucher-Chéné, D., Thibaudeau, E., Sauvé, G., Lavigne, K. M., & Lepage, M. (2021). Understanding others as a mediator between verbal memory and negative symptoms in schizophrenia-spectrum disorder. J PsychiatrRes, 143, 429-435.
  5. Henry, A., Raucher-Chéné, D., Obert, A., Gobin, P., Vucurovic, K., Barrière, S., Sacré, S., Portefaix, C., Gierski, F., Caillies, S., & Kaladjian, A. (2021). Investigation of the neural correlates of mentalizing through the Dynamic Inference Task, a new naturalistic task of social cognition. NeuroImage, 243, 118499.